Fimasartan Optimal Reduction Targeting Elevated Blood Pressure: the FORTE Study

Boryung

Status: Completed

Conditions: Hypertension

Treatments: Procedure: Home Blood Pressure

Study type: Observational

Funder types: Industry

Identifiers

NCT03254914

BR-FMS-OS-403

Details and patient eligibility

About

The purpose of this study is to evaluate the effect of home blood pressure monitoring on controlling blood pressure and correlation between home blood pressure and clinic blood pressure in hypertensive patients receiving two or more concomitant antihypertensive agents including fimasartan

Full description

A multi-center, cluster-randomized, prospective, observational study

Enrollment: 3,554 patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects who voluntarily signed informed consent for participating in this clinical study
• Male and female over the age of 19
• Hypertensive patients receiving two or more concomitant anti-hypertensive agents including fimasartan

Exclusion criteria

• Renal dialysis patients.
• Diabetic nephropathy patients taking angiotensin-converting enzyme inhibitor.
• Severe renal disorder
• Subjects with hereditary disorders of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption.
• Medical history with hypersensitivity to Fimasartan
• Pregnant women or lactating female.
• Participate in another clinical trial.

Trial design

3,554 participants in 2 patient groups

Control Site

Description:

Measure Clinic Blood Pressure

Test Site

Description:

Measure Clinic Blood Pressure and Home Blood Pressure

Treatment:

Procedure: Home Blood Pressure